Biocon shares experienced a significant jump of over 6% on Tuesday. Viatris-owned Mylan intends to sell a substantial stake, exiting the Indian drugmaker. This stake sale represents 5.64% of Biocon’s outstanding shares. The offer’s floor price was set at a discount to the previous closing price. Block deals totaling nearly nine crore shares occurred in early trading hours.
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.